University of California San Francisco
Give to UCSF
UCSF scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal tissue.
James Wells, PhD, chair of Pharmaceutical Chemistry, has been elected as a fellow to the prestigious National Academy of Inventors.
UCSF researchers has discovered that single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
Scientists at the UNC School of Medicine (UNC) and UCSF have created a general tool to probe the activity of orphan receptors, illuminating their roles in behavior and making them accessible for drug discovery.
A research team led by UCSF scientists has identified a molecular switch capable of converting unhealthy white fat into healthy, energy-burning brown fat in mice.
UCSF Sandler Fellow Joseph Bondy-Denomy studies the native roles of CRISPR and anti-CRISPR proteins in bacteria and phages.
UCSF ranks among the top five schools in the world in seven subject areas, according to the 2015 U.S. News & World Report's 2016 Best Global Universities rankings.
The National Institutes of Health (NIH) has awarded seven grants to UCSF scientists to pursue innovative approaches to major contemporary challenges in biomedical research.
A virus is nature’s efficient little killer. They’re really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
UCSF researchers have engineered a molecular “on switch” that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for cancer.
Zev Gartner is working to building a fully functioning 3-D human breast tissue that will allow him to test potential cancer therapies, an innovation that's earned him a spot among Popular Science's "Brilliant 10" this year.
Researchers at UCSF are leading a five-year, $10 million research project dedicated to pediatric cancer, funded by the first grant of its kind to focus on a molecular pathway that underlies many cancers.
Emmanuelle Passegué’s passion for blood is focused on rejuvenation and longer life. This may sound like something out of a vampire story, but her work is rooted in a different kind of mystery: one that could hold the key to how well we age and respond to diseases.
UCSF researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.
